RxDoctor Payments Data

Amar Kishan, MD

Radiation Oncology · Los Angeles, CANPI 1871869339

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $55,317 of the $73,718 with a category attached, or 75.0%. 13 manufacturers reported payments, led by Varian Medical Systems, Inc. at 30.7% of the total. Among radiation oncology clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$73,718in general payments, 2019–2025

Across 55 payments — averaging $1340.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Varian Medical Systems, Inc.$23K
  • Lantheus Medical Imaging, Inc.$15K
  • Viewray Technologies Inc$14K
  • Siemens Medical Solutions USA, Inc.$8K
  • Progenics Pharmaceuticals, Inc.$3K
  • Boston Scientific$3K
  • plus $8K from 7 others
$984,863in research payments, 2019–2025

Across 40 payments — averaging $24,622 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Viewray Technologies Inc$450K
  • Janssen Research & Development, LLC$400K
  • Progenics Pharmaceuticals, Inc.$99K
  • Siemens Medical Solutions USA, Inc.$35K

What the payments were for

  • Consulting fees$55,31775%
  • Speaking & faculty fees$15,19121%
  • Grants$1,5002%
  • Travel & lodging$3200%
  • Food & beverage$1,3912%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$73,718 in reported general payments places this provider in the 95th percentile of 627 radiation oncology providers in California.

See all radiation oncology providers in California

Medicare billing

Part B allowed, 2024
$534,177
Medicare patients
548
Services billed
3,474

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Tamsulosin Hcl68$969

Paid to pharmacies, not to this prescriber.

Other radiation oncology in Los Angeles

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →